help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fantone, J. C.
Right arrow Articles by Ward, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fantone, J. C.
Right arrow Articles by Ward, P. A.

American Journal of Pathology, Vol 115, 9-16, Copyright © 1984 by American Society for Investigative Pathology


REGULAR ARTICLES

Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production

JC Fantone, WA Marasco, LJ Elgas and PA Ward

Prostaglandins (PGs) of the E series and PGI2 have been shown to inhibit acute inflammatory reactions in vivo and polymorphonuclear leukocyte (PMN), chemotaxis, lysosomal enzyme release, and superoxide anion (O-2) production in vitro. This inhibition of neutrophil stimulation by PGEs and PGI2 has been correlated with their ability to increase intracellular cyclic adenosine monophosphate (cAMP) levels. However, the mechanism(s) by which PGEs and PGI2 alter the complex biochemical and biophysical events associated with stimulus-response coupling in the neutrophil are not clear. It is reported here that both PGEs and PGI2 in micromolar concentrations inhibit formyl-methionyl- leucyl-phenylalanine (FMLP)- and zymosan-induced lysosomal enzyme secretion and superoxide anion production in a dose-dependent manner. No preincubation time of PMNs with the prostaglandins is required for inhibition. Addition of PGEs 10 seconds or later after FMLP stimulation does not alter the biologic response of the neutrophils to the stimulus, suggesting that the prostaglandin inhibition effects early events associated with stimulus-response coupling in the neutrophil. Prostaglandin inhibition of lysosomal enzyme release by the calcium ionophore A23187 was overcome by increasing the extracellular ionophore and/or calcium concentration, suggesting that PGs may modulate intracellular free calcium levels in a manner similar to that observed with platelets. Inhibition of phorbol myristate acetate (PMA)-induced neutrophil lysosomal enzyme secretion by PGEs and PGI2 was overcome by increasing concentrations of PMA. However, neither PGEs nor PGI2 altered O-2 production by PMA-treated neutrophils. These data indicate a dissociation between PMA-stimulated O-2 production and lysosomal enzyme release. These findings are consistent with the hypothesis that inhibition of neutrophil stimulation by PGEs and PGI2 is a result of increased intracellular cyclic AMP levels and modulation of calcium- dependent events. In addition, the data indicate that there are at least two mechanisms by which PMNs can be stimulated to produce O-2, one inhibited by PGEs and PGI2 and a second independent of prostaglandin modulation.


This article has been cited by other articles:


Home page
ICVTSHome page
N. Yakut, H. Yasa, B. Bahriye Lafci, R. Ortac, E. Tulukoglu, M. Aksun, C. Ozbek, and A. Gurbuz
The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study
Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 235 - 239.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C.-H. CHIANG, K. WU, C.-P. YU, H.-C. YAN, W.-C. PERNG, and C.-P. WU
Hypothermia and Prostaglandin E1 Produce Synergistic Attenuation of Ischemia-Reperfusion Lung Injury
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1319 - 1323.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
Y. Matsuzaki, M. Edagawa, M. Maeda, T. Shimizu, R. Sekiya, K. Nakamura, and T. Onitsuka
Beneficial effect of prostaglandin E1 on blood flow to the gastric tube after esophagectomy
Ann. Thorac. Surg., April 1, 1999; 67(4): 908 - 910.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C.-H. Chiang, K. Hsu, H.-C. Yan, H.-J. Harn, and D.-M. Chang
PGE1, dexamethasone, U-74389G, or Bt2-cAMP as an additive to promote protection by UW solution in I/R injury
J Appl Physiol, August 1, 1997; 83(2): 583 - 590.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Kukkonen, L. J. Heikkila, K. Verkkala, S. P. Mattila, and H. Toivonen
Prostaglandin E1 or Prostacyclin in Euro-Collins Solution Fails to Improve Lung Preservation
Ann. Thorac. Surg., December 1, 1995; 60(6): 1617 - 1622.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Yu, S. J. Suchard, R. Nairn, and R. Jove
Dissociation of Mitogen-activated Protein Kinase Activation from the Oxidative Burst in Differentiated HL-60 Cells and Human Neutrophils
J. Biol. Chem., June 30, 1995; 270(26): 15719 - 15724.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
A. El-Gatit, A. Belboul, N. Al-Khaja, G. Radberg, A. El-Bishry, D. Roberts, and G. William-Olsson
Effects of Alprostadil (synthetic prostaglandin E1) on red and white cell filterability during cardiopulmonary bypass
Perfusion, January 1, 1992; 7(1): 21 - 26.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
W. W. Nichols, J. Mehta, T. J. Wargovich, D. Franzini, and D. Lawson
Reduced Myocardial Neutrophil Accumulation and Infarct Size Following Thromboxane Synthetase Inhibitor or Receptor Antagonist
Angiology, March 1, 1989; 40(3): 209 - 221.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Society for Investigative Pathology.